Generic Name:
prasterone
Project Status:
Complete
Therapeutic Area:
Postmenopausal vulvovaginal atrophy
Manufacturer:
Lupin Pharma Canada Ltd.
Brand Name:
Intrarosa
Project Line:
Reimbursement Review
Project Number:
SR0707-000
NOC Status at Filing:
Post NOC
Details
Manufacturer Requested Reimbursement Criteria1:
Intrarosa (prasterone vaginal ovules) is indicated for treatment of postmenopausal vulvovaginal atrophy.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Intrarosa (prasterone vaginal ovules) is indicated for treatment of postmenopausal
vulvovaginal atrophy.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.